® Insider Prophets® Report

Catalyst Pharmaceuticals Inc (CPRX)

Insider buys

Insider buys
McEnany, Patrick J.
O'Keeffe, Charles B.

$6

$5
Price Chart

$4

$3

$2
Ingenito, Gary
Insider sells

Insider sells
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan '21
Insiders with a current Prophet Rating are displayed in bold . = Buy = Sell = Mixed
Size of Insider Trades:
= 1-5,000 shs. = 5,001-20,000 shs. = 20,001-150,000 shs. = 150,001-500,000 shs. = 500,001+ shs.
© Vickers Stock Research Corporation 2021 Page 1
 ® Insider Prophets® Report
Catalyst Pharmaceuticals Inc (CPRX)
Insider Prophet Ratings
Methodology: To identify Insider Prophets, we have analyzed more than 40,000 insider trades over the past
24 months. Our goal is to identify profitable trades – and the Insiders behind them. For each trade, we focus
first on the magnitude of change in the stock price during a specified period after a trade. Gains must be
absolute. Depending on the success of a trade, an Insider earns a per-trade rating of 3, 5 or 7. We add extra
weight to a Rating if the trade represents a large dollar amount or a high percentage of the Insider's holdings.
Our Average Ratings reflect the Total Prophet Rating divided by the number of trades. The higher the Average
Rating, the more successful the Insider. Macro Results: According to our analysis, buyers as a group are better
at predicting stock price movements. We calculated that 60% of insider buys resulted in meaningful stock
price gains at the end of six months. As for sellers, only 40% of the stocks that insiders sold were lower within
30 days after the sale. Distribution: At the top end of our scale, less than 2% of Insider trades earned a score
of 7-9, which to us represented a significant investment decision that preceded a significant change in price.
These were the most successful Insider trades. At the next level, 6, the percentage of trades rose to 11%. At
the third level, 3-5, which indicated a meaningful absolute change in the stock price, the percentage of trades
reached 30%. Thus, more than 50% of the trades earned a score of zero.

Insider buy data Insider sell data

Total Date of Total
Insider Prophets for Average Buy Rating Timing Prophet Last Average Sell Rating Timing Prophet Date of
Catalyst Pharmaceuticals Inc Worse Better Success Rate Rating Purchase Worse Better Success Rate Rating Last Sale
Denkhaus, Donald A. 0 1 2 3 4 5 6 7 8 9 2 of 2 13 12/27/2018 NA -- -- --
Ingenito, Gary NA -- -- -- 0 1 2 3 4 5 6 7 8 9 3 of 3 21 12/5/2019
McEnany, Patrick J. 0 1 2 3 4 5 6 7 8 9 2 of 3 12 9/30/2020 NA -- -- --
O'Keeffe, Charles B. 0 1 2 3 4 5 6 7 8 9 1 of 2 5 9/30/2020 NA -- -- --

© Vickers Stock Research Corporation 2021 Page 2

 ® Insider Prophets® Report
Catalyst Pharmaceuticals Inc (CPRX)
Chronological Insider Trades
This section gives a chronological listing of the insider trading activity of executive officers within Catalyst Pharmaceuticals Inc. From left to right, the columns give the details of the transactions by showing the name and title
of the person who made the transaction on a particular date. It further shows that they bought or sold a certain number of shares at a particular price through a certain type of transaction. Finally, it shows what percent of the
person's holdings were traded and how many shares the person held once the transaction was complete.

Transactions
Name, Title Transaction During 2020 # of Shares Price($) Type % of Holdings Traded Now Holds
Coelho, Philip H., DIR Bought 12/22 1,333 -- Direct, Non Open Market 0.61 216,760
Daly, Richard J., DIR Bought 12/22 1,333 -- Direct, Non Open Market 100.00 1,333
Denkhaus, Donald A., DIR Bought 12/22 1,333 -- Direct, Non Open Market 0.59 226,333
Elsbernd, Brian, CCO Bought 12/22 14,666 -- Direct, Non Open Market 100.00 14,666
Grande, Alicia, CFO Bought 12/22 14,666 -- Direct, Non Open Market 3.57 411,012
Grande, Alicia, CFO Sold 12/22 3,571 -- Direct, Non Open Market 0.87 407,441
Ingenito, Gary, OFF Bought 12/22 14,666 -- Direct, Non Open Market 100.00 14,666
Ingenito, Gary, OFF Sold 12/22 3,668 3.45 Direct, Sell 25.01 10,998
McEnany, Patrick J., CEO Bought 12/22 30,833 -- Direct, Non Open Market 0.64 4,818,526
McEnany, Patrick J., CEO Sold 12/22 7,507 -- Direct, Non Open Market 0.16 4,811,019
Miller, Steve, COO Bought 12/22 20,000 -- Direct, Non Open Market 2.95 677,687
O'Keeffe, Charles B., DIR Bought 12/22 1,333 -- Direct, Non Open Market 0.24 561,709
Tierney, David S., DIR Bought 12/22 1,333 -- Direct, Non Open Market 0.43 306,874
McEnany, Patrick J., CEO Bought 09/30 15,000 2.97 Direct, Buy 0.31 4,787,693
O'Keeffe, Charles B., DIR Bought 09/30 7,000 2.99 Direct, Buy 1.25 560,376

Transactions
Name, Title Transaction During 2019 # of Shares Price($) Type % of Holdings Traded Now Holds
Ingenito, Gary, OFF Sold 12/05 150,000 4.82 Direct, Sell 100.00 0
Ingenito, Gary, OFF Bought 12/04 150,000 2.53 Direct, Option -- 150,000
Ingenito, Gary, OFF Bought 11/27 100,000 1.13 Direct, Option -- 100,000
Ingenito, Gary, OFF Sold 11/27 100,000 4.66 Direct, Sell 100.00 0
Ingenito, Gary, OFF Sold 11/21 100,000 4.50 Direct, Sell 100.00 0
Ingenito, Gary, OFF Bought 11/20 100,000 0.79 Direct, Option -- 100,000
O'Keeffe, Charles B., DIR Bought 10/11 10,000 4.70 Direct, Buy 1.81 553,376
McEnany, Patrick J., CEO Bought 10/03 10,000 4.89 Direct, Buy 0.21 4,772,693
McEnany, Patrick J., CEO Bought 06/11 25,000 3.23 Direct, Buy 0.52 4,762,693

The information provided in this material is supplied by Vickers (Vickers Stock Research Corporation), which is not affiliated with Charles Schwab & Co., Inc. (“Schwab”) or any of Schwab’s affiliates. None of the information constitutes a recommendation by
Schwab or a solicitation of an offer to buy or sell any securities. The information is not intended to provide tax, legal or investment advice. Schwab does not guarantee the suitability or potential value of any particular investment or information source.
Neither Schwab nor Vickers guarantees the accuracy, timeliness, completeness or correct sequencing of this information nor warrants any results from use of the information.
© Vickers Stock Research Corporation 2021 Page 3